Fig. 4From: Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysisHDL functionality. (Panel a) Cholesterol efflux: HDL was isolated from subjects with DKD and controls and utilized as an acceptor of cellular cholesterol. Bone marrow-derived macrophages (BMDMs) overloaded with acetylated LDL and 14C-cholesterol were incubated with 50āĪ¼g of HDL/mL of medium for 6āh. Cholesterol efflux was determined after measuring the radioactivity in the culture medium and that remaining in cells, which was calculated as 14C-cholesterol in the medium/14C-cholesterol in the medium +14C-cholesterol in cells Ćā100. Control incubations were performed in the presence of DMEM/FAFA in the absence of HDL, and the results were subtracted from those obtained in the presence of HDL. (Panels b and c) Antioxidant activity: The lag time (panel b) and the maximum rate of LDL oxidation (panel c) were determined in incubations with LDL (40āĪ¼g of protein) isolated from a healthy donor with CuSO4 solution and HDL from DKD or controls (80āĪ¼g of protein). (Panels d and e) Anti-inflammatory activity: BMDMs overloaded with acetylated LDL (50āĪ¼g/mL) were treated with HDL (50āĪ¼g/mL) for 24āh. After washing, cells were treated with LPS (1āĪ¼g/mL) for 24āh, and interleukin-6 (IL-6, panel d) and TNF-alpha (panel e) levels in the medium were determined by ELISA. The results were compared by the Kruskal-Wallis test with the Holm-Sidak posttest or Studentās t testBack to article page